A recent
report published by Infinium Global Research on cardiac arrest treatment market
provides an in-depth analysis of segments and sub-segments in the global as well
as regional cardiac arrest treatment market. The study also highlights the
impact of drivers, restraints, and macro indicators on the global and regional
cardiac arrest treatment market over the short term as well as long term. The
report is a comprehensive presentation of trends, forecast and dollar values of
global cardiac arrest treatment market. According to the report, the global
cardiac arrest treatment market is projected to grow at a CAGR of 4.8% over the
forecast period of 2019-2025.
A cardiac arrest is a situation when the heart suddenly stops
beating. This situation occurs due to a heart attack when oxygen demand for the
hearth does not meet as per the requirement and results in the mortality of
heart muscles cells. Additionally, there are several other factors, which
causes the cardiac arrest problem as Coronary artery disease, Cardiomyopathy,
Long QT syndrome, and Brugada syndrome. The coronary artery disease is the most
common cause of the sudden cardiac arrest among the below 35 years’ age group
people. The cardiomyopathy situation
causes the heart muscle to develops abnormal size and creates a cardiac arrest
problem. Moreover, the long QT syndrome and Brugada syndrome causes abnormal
heart rate and develops a cardiac arrest problem inside the body.
The continuously changing food and living habit and changing work culture are helping to grow the cardiac arrest problem around the world. The growing smoking habits among the youth and middle-class consumers are boosting the cardiac arrest problem among them. Further, the patient suffering from the cardiac arrest problem needs treatment within a very short period of time to save the life of the person. There are two methods to treat the cardiac arrest problem- drugs and medical devices. The corticosteroids, fibrinolytic drugs, beta blockers, anticholinergic drugs, and others are used to treat the person suffering from cardiac arrest issues. Cardiac Resynchronization therapy, defibrillators are commonly used devices to treat a person suffering from cardiac arrest treatment. The anti-arrhythmic drugs are used for the emergency period to save the person from arrhythmias or potential arrhythmia problem. Further, beta blockers medicines are used to treat people, who are expected to face cardiac arrest problem in the near future. When a patent condition becomes stable, they are advised to use a different type of mechanical devices as implantable cardioverter-defibrillator (ICD) to escape a life-threatening situation in the near future.
North
America is the leading region of the cardiac arrest treatment market, owing to the
presence of the large patient pool in this region. As per the American Heart
Association, more than 320,000 deaths (out of hospital) occur every year due to
cardiac arrest problems in the United States alone. Further, more than 7,20,000
new heart attack and 3,35,000 recurrent occurs every year in the United States
alone. Additionally, a person suffering from this type of problem in other
countries as Indian, China prefers to go to the United States of America to get
better treatment, owing to the availability of the better health care facility
and trained health care professionals. This medical tourism is boosting the
growth of the cardiac arrest treatment market of North America
The report on
global cardiac arrest treatment market covers segments such as treatment, and
sales channel. On the basis of treatment, the sub-markets include drug, and medical
devices. On the basis of sales channel, the sub-markets include hospitals, independent
pharmacies and other sales channel.
The report
provides profiles of the companies in the market such as Boston Scientific
Corporation, GE Healthcare, Abbott Laboratories, Bristol-Myers Squibb Company,
Novartis International AG, Johnson & Johnson, Pfizer Inc., and Amgen Inc.
The report
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The IGR-Growth
Matrix analysis given in the report brings an insight into the investment areas
that existing or new market players can consider. The report provides insights
into the market using analytical tools such as Porter's five forces analysis
and DRO analysis of cardiac arrest treatment market. Moreover, the study
highlights current market trends and provides forecast from 2019-2025. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.
Please Choose One of them.